In obesity-related endothelial dysfunction, several factors come into play, including endothelial barrier disruption, the presence of oxidized low-density lipoprotein (oxLDL), diminished nitric oxide (NO) bioavailability and eNOS uncoupling, and increased reactive oxygen species (ROS) production. This evidence concerns the gene NOS3 and endothelial dysfunction.